Brazil Pharma Defines FO
May 10, 2012
Brazil Pharma plans to begin investor meetings June 4 for an approximately BRL600m ($306m) equity follow-on, ahead of a June 21 pricing, it...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.